277 related articles for article (PubMed ID: 30504319)
1. Richter transformation in the era of novel agents.
Ding W
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):256-263. PubMed ID: 30504319
[TBL] [Abstract][Full Text] [Related]
2. Richter transformation of chronic lymphocytic leukemia in the era of novel agents.
Wang Y; Ding W
Clin Adv Hematol Oncol; 2020 Jun; 18(6):348-357. PubMed ID: 32649656
[TBL] [Abstract][Full Text] [Related]
3. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
Jamroziak K; Tadmor T; Robak T; Polliack A
Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
[TBL] [Abstract][Full Text] [Related]
4. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
5. A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.
Rogers KA; Huang Y; Ruppert AS; Salem G; Stephens DM; Heerema NA; Andritsos LA; Awan FT; Byrd JC; Flynn JM; Maddocks KJ; Jones JA
Br J Haematol; 2018 Jan; 180(2):259-266. PubMed ID: 29193006
[TBL] [Abstract][Full Text] [Related]
6. Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents.
Levy Yurkovski I; Tadmor T
Acta Haematol; 2024; 147(1):73-83. PubMed ID: 37666234
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.
Reinert CP; Federmann B; Hofmann J; Bösmüller H; Wirths S; Fritz J; Horger M
Eur Radiol; 2019 Dec; 29(12):6911-6921. PubMed ID: 31236702
[TBL] [Abstract][Full Text] [Related]
8. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.
Gángó A; Kiss R; Farkas P; Hanna E; Demeter J; Deák B; Lévai D; Kotmayer L; Alpár D; Matolcsy A; Bödör C; Mátrai Z; Timár B
Pathology; 2022 Feb; 54(1):95-103. PubMed ID: 34332791
[TBL] [Abstract][Full Text] [Related]
9. [Richter syndrome: report of a case].
Chen DB; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):487-8. PubMed ID: 21055184
[No Abstract] [Full Text] [Related]
10. The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia: TP53 Disruption, Richter, and Beyond.
Ding W
Hematol Oncol Clin North Am; 2021 Aug; 35(4):739-759. PubMed ID: 34174984
[TBL] [Abstract][Full Text] [Related]
11. Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation.
Kanagal-Shamanna R; Jain P; Patel KP; Routbort M; Bueso-Ramos C; Alhalouli T; Khoury JD; Luthra R; Ferrajoli A; Keating M; Jain N; Burger J; Estrov Z; Wierda W; Kantarjian HM; Medeiros LJ
Cancer; 2019 Feb; 125(4):559-574. PubMed ID: 30508305
[TBL] [Abstract][Full Text] [Related]
12. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.
Ding W; LaPlant BR; Call TG; Parikh SA; Leis JF; He R; Shanafelt TD; Sinha S; Le-Rademacher J; Feldman AL; Habermann TM; Witzig TE; Wiseman GA; Lin Y; Asmus E; Nowakowski GS; Conte MJ; Bowen DA; Aitken CN; Van Dyke DL; Greipp PT; Liu X; Wu X; Zhang H; Secreto CR; Tian S; Braggio E; Wellik LE; Micallef I; Viswanatha DS; Yan H; Chanan-Khan AA; Kay NE; Dong H; Ansell SM
Blood; 2017 Jun; 129(26):3419-3427. PubMed ID: 28424162
[TBL] [Abstract][Full Text] [Related]
13. Are we closer to a standard of care for Richter's syndrome? Novel treatments on the horizon.
Pham N; Coombs CC; O'Brien S
Expert Rev Hematol; 2024; 17(4-5):117-126. PubMed ID: 38693662
[TBL] [Abstract][Full Text] [Related]
14. Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1-2 study.
Eyre TA; Schuh A; Wierda WG; Brown JR; Ghia P; Pagel JM; Furman RR; Cheung J; Hamdy A; Izumi R; Patel P; Wang MH; Xu Y; Byrd JC; Hillmen P
Lancet Haematol; 2021 Dec; 8(12):e912-e921. PubMed ID: 34735860
[TBL] [Abstract][Full Text] [Related]
15. Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients.
Parikh SA; Rabe KG; Call TG; Zent CS; Habermann TM; Ding W; Leis JF; Schwager SM; Hanson CA; Macon WR; Kay NE; Slager SL; Shanafelt TD
Br J Haematol; 2013 Sep; 162(6):774-82. PubMed ID: 23841899
[TBL] [Abstract][Full Text] [Related]
16. Haematological cancer: Richter's transformation in CLL-a distinct lymphoma.
Jain P; Young KH
Nat Rev Clin Oncol; 2014 Jan; 11(1):6-8. PubMed ID: 24281057
[TBL] [Abstract][Full Text] [Related]
17. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
[TBL] [Abstract][Full Text] [Related]
18. Richter transformation of CLL.
Jain N; Keating MJ
Expert Rev Hematol; 2016 Aug; 9(8):793-801. PubMed ID: 27351634
[TBL] [Abstract][Full Text] [Related]
19. Transformation in Low-grade B-cell Neoplasms.
Montgomery ND; Mathews SP
Surg Pathol Clin; 2016 Mar; 9(1):79-92. PubMed ID: 26940269
[TBL] [Abstract][Full Text] [Related]
20. Richter Transformation Arising From Chronic Lymphocytic Leukemia.
Barnes Rogers B
Clin J Oncol Nurs; 2022 Feb; 26(1):14-17. PubMed ID: 35073287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
